Spironolactone 50 mg Tablets Unit Carton Label (Image 01)
Spironolactone Tablet, Film Coated
Product Images NDC 51079-103
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 51079-103). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spironolactone 25 mg Tablets Unit Carton Label (Image 02)
Unit Carton (Image 03)
Unit Carton (Image 04)
Spironolactone Tablets, USP are a prescription medication containing 25mg of Spironolactone. The usual dosage should be taken as instructed by a healthcare provider. These tablets should be stored in controlled room temperature and protected from light. They are manufactured by Mylan Pharmaceuticals Inc. at their Morgantown facility.*
Spironolactone 100 mg Tablets Unit Carton Label (Image 05)
This is a packaging warning for a medication from Mylan Inc. The unit dose package is not child resistant and is only meant for institutional use. It is important to keep all drugs, including this one, out of the reach of children. The container provides light-resistance and there is a window to view the lot number and expiration date. No specific medication or dosage information is included in the text.*
Unit Carton (Image 06)
This is a description of Spironolactone tablets, USP with the National Drug Code (NDC) 51079-97 and NDC 51079-979-20. The tablets are film-coated and contain 50mg of Spironolactone, USP. The package contains 100 tablets, and the usual dosage should be determined by accompanying prescribing information. The tablets should be stored at 20 to 25°C (68 to 77°F), protected from light, and regulated as per USP controlled room temperature guidelines. The manufacturer is Mylan Pharmaceuticals Inc. based in Morgantown, WY 26505 USA.*
Image 07
This is a warning label for a medication package. The package is not child-resistant and should be used only in institutional settings. The label advises to keep the medication out of reach of children. The container provides light-resistance and the lot number and expiration date are visible through a window. The medication is manufactured by Mylan and the address is Rockford, USA.*
Image 08
This is a description of tablets containing 100mg Spironolactone, a prescription drug indicated for use with accompanying prescribing information. The tablets are film-coated and packaged with 80 tablets per container. They should be stored in controlled room temperature and protected from light. The manufacturer is Mylan Pharmaceuticals Inc. located in Morgantown, USA.*
Image 09
This text describes a unit dose package that is not child resistant and is intended for institutional use only. It warns to keep all drugs out of reach of children and notes that the container provides light-resistance. There is a window on the container displaying the lot number and expiration date. The package is associated with Mylan and has its location in Rockford, Illinois, USA.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
